Anti-LRRC4/ NAG14/ NGL-2 monoclonal antibody

Anti-LRRC4/ NAG14/ NGL-2 antibody for FACS & in-vivo assay

Target products collectionGo to LRRC4/LRRC4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0762-Ab-1/ GM-Tg-hg-MP0762-Ab-2Anti-Human LRRC4 monoclonal antibodyHuman
GM-Tg-rg-MP0762-Ab-1/ GM-Tg-rg-MP0762-Ab-2Anti-Rat LRRC4 monoclonal antibodyRat
GM-Tg-mg-MP0762-Ab-1/ GM-Tg-mg-MP0762-Ab-2Anti-Mouse LRRC4 monoclonal antibodyMouse
GM-Tg-cynog-MP0762-Ab-1/ GM-Tg-cynog-MP0762-Ab-2Anti-Cynomolgus/ Rhesus macaque LRRC4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0762-Ab-1/ GM-Tg-felg-MP0762-Ab-2Anti-Feline LRRC4 monoclonal antibodyFeline
GM-Tg-cang-MP0762-Ab-1/ GM-Tg-cang-MP0762-Ab-2Anti-Canine LRRC4 monoclonal antibodyCanine
GM-Tg-bovg-MP0762-Ab-1/ GM-Tg-bovg-MP0762-Ab-2Anti-Bovine LRRC4 monoclonal antibodyBovine
GM-Tg-equg-MP0762-Ab-1/ GM-Tg-equg-MP0762-Ab-2Anti-Equine LRRC4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0762-Ab-1/ GM-Tg-hg-MP0762-Ab-2; GM-Tg-rg-MP0762-Ab-1/ GM-Tg-rg-MP0762-Ab-2;
GM-Tg-mg-MP0762-Ab-1/ GM-Tg-mg-MP0762-Ab-2; GM-Tg-cynog-MP0762-Ab-1/ GM-Tg-cynog-MP0762-Ab-2;
GM-Tg-felg-MP0762-Ab-1/ GM-Tg-felg-MP0762-Ab-2; GM-Tg-cang-MP0762-Ab-1/ GM-Tg-cang-MP0762-Ab-2;
GM-Tg-bovg-MP0762-Ab-1/ GM-Tg-bovg-MP0762-Ab-2; GM-Tg-equg-MP0762-Ab-1/ GM-Tg-equg-MP0762-Ab-2
Products NameAnti-LRRC4 monoclonal antibody
Formatmab
Target NameLRRC4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LRRC4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species LRRC4/ NAG14/ NGL-2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000068human LRRC4 Lentivirus particle
    ORF Viral VectorpGMLV000068human LRRC4 Lentivirus plasmid
    ORF Viral VectorpGMLPm004069mouse Lrrc4 Lentivirus plasmid
    ORF Viral VectorvGMLPm004069mouse Lrrc4 Lentivirus particle


    Target information

    Target IDGM-MP0762
    Target NameLRRC4
    Gene ID64101,192198,641521,698610,607997,101100118,525767,100056742
    Gene Symbol and SynonymsLRRC4,MBAG1,NAG14,NGL-2,NGL2,NLG-2
    Uniprot AccessionQ9HBW1,Q45R42
    Uniprot Entry NameLRRC4_HUMAN,LRRC4_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000128594
    Target ClassificationN/A

    The target: LRRC4, gene name: LRRC4, also named as NAG14, NGL-2. This gene is significantly downregulated in primary brain tumors. The exact function of the protein encoded by this gene is unknown. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.